Preferred Label : roxadustat;

Obsolete resource : false;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/evrenzo
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
roxadustat
roxadustat
Anemia of chronic renal failure (disorder)
anemia
renal insufficiency, chronic
adult
aged
administration, oral
roxadustat
Hypoxia-Inducible Factor-Proline dioxygenases
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
fertility
drug evaluation, preclinical

---
Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.